Momenta, Sandoz Again Try To Nix Amphastar's Antitrust Suit
Amphastar Pharmaceuticals Inc. alleges that Momenta Pharmaceuticals Inc. tricked the U.S. Pharmacopeial Convention into adopting a method to test enoxaparin without disclosing that it held a patent that covered the test, but Momenta and Sandoz Inc. said in a motion to dismiss that the method was not mandatory.
The U.S....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login